Neratinib maleate is a potent tyrosine kinase inhibitor primarily indicated as an adjuvant therapy for patients with HER2-positive early-stage breast cancer following trastuzumab treatment. By blocking… Read more
Neratinib maleate is a potent tyrosine kinase inhibitor primarily indicated as an adjuvant therapy for patients with HER2-positive early-stage breast cancer following trastuzumab treatment. By blocking specific receptor tyrosine kinases, this therapeutic agent helps to inhibit tumor growth and metastasis. This category provides a comprehensive selection of Neratinib maleate reference standards, which are indispensable for precise analytical testing, method validation, and rigorous quality control in pharmaceutical research. The collection includes pharmacopeial and non-pharmacopeial impurities, as well as relevant metabolites and stable isotope labelled compounds. These materials are essential for accurate impurity profiling and supporting the development of reliable analytical methods throughout the drug manufacturing lifecycle. Laboratories rely on these high-quality, characterized reference materials to ensure the purity, safety, and regulatory compliance of their pharmaceutical products.